Preparation and Characterization of Calcium Phosphate Cement
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32804
Preparation and Characterization of Calcium Phosphate Cement

Authors: W. Thepsuwan, N. Monmaturapoj

Abstract:

Calcium phosphate cement (CPC) is one of the most attractive bioceramics due to its moldable and shape ability to fill complicated bony cavities or small dental defect positions. In this study, CPC was produced by using mixture of tetracalcium phosphate (TTCP, Ca4O(PO4)2) and dicalcium phosphate anhydrous (DCPA, CaHPO4) in equimolar ratio (1/1) with aqueous solutions of acetic acid (C2H4O2) and disodium hydrogen phosphate dehydrate (Na2HPO4.2H2O) in combination with sodium alginate in order to improve theirs moldable characteristic. The concentration of the aqueous solutions and sodium alginate were varied to investigate the effect of different aqueous solutions and alginate on properties of the cements. The cement paste was prepared by mixing cement powder (P) with aqueous solution (L) in a P/L ratio of 1.0g/0.35ml. X-ray diffraction (XRD) was used to analyses phase formation of the cements. Setting time and compressive strength of the set CPCs were measured using the Gilmore apparatus and Universal testing machine, respectively. The results showed that CPCs could be produced by using both basic (Na2HPO4.2H2O) and acidic (C2H4O2) solutions. XRD results show the precipitation of hydroxyapatite in all cement samples. No change in phase formation among cements using difference concentrations of Na2HPO4.2H2O solutions. With increasing concentration of acidic solutions, samples obtained less hydroxyapatite with a high dicalcium phosphate dehydrate leaded to a shorter setting time. Samples with sodium alginate exhibited higher crystallization of hydroxyapatite than that of without alginate as a result of shorten setting time in a basic solution but a longer setting time in an acidic solution. The stronger cement was attained from samples using the acidic solution with sodium alginate; however the strength was lower than that of using the basic solution.

Keywords: Calcium phosphate cements, TTCP, DCPA, hydroxyapatite, properties.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1097307

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2525

References:


[1] C.D. Friedman, P.D. Costantino, S. Takagi, L.C. Chow, “Bone Source hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction,” J. Biomed. Mater. Res., Vol. 43,1998, pp. 428–432.
[2] D.B. Kamerer, B.E. Hirsch, C.H. Snyderman, P. Costantino, C.D. Friedman, “Hydroxyapatite cement: a new method for achieving watertight closure in transtemporal surgery,” Am. J. Otol., vol. 15, 1994, pp. 47–49.
[3] B.R. Constantz, I.C. Ison, M.T. Fulmer, R.D. Poser, S.T. Smith, M. VanWagoner,et al., “Skeletal repair by in situ formation of the mineral phase of bone,” Science, vol 267, 1995, pp. 1796–1799.
[4] W.G. Horstmann, C.C.P.M. Verheyen, R. Leemans, “An injectable calcium phosphate cement as a bone-graft substitute in the treatment of displaced lateral tibial plateau fractures,” Injury, vol. 34, 2003, pp. 141– 144.
[5] E.J. Strauss, K.A. Egol, “The management of ankle fractures in the elderly,” Injury, vol 38 (Suppl. 3), 2007, pp. S2–S9.
[6] P.A. Liverneaux, “Osteoporotic distal radius curettage—filling with an injectable calcium phosphate cement. A cadaveric study,” Eur. J. Orthop. Surg. Traumatol., vol. 15, 2004, pp. 1–6.
[7] R.D. Welch, H. Zhang, D.G. Bronson, “Experimental tibial plateau fractures augmented with calcium phosphate cement or autologous bone graft,” J. Bone Joint Surg., vol. 85, 2003, pp. 222.
[8] A. Aral, S. Yalçin, Z.C. Karabuda, A. Anil, J.A. Jansen, Z. Mutlu, “Injectable calcium phosphate cement as a graft material for maxillary sinus augmentation: an experimental pilot study,” Clin. Oral Implants Res., vol. 19, 2008, pp. 612–617.
[9]
[9] M.P. Ginebra, T. Traykova, J.A. Planell, “Calcium phosphate cements: competitive drug carriers for the musculoskeletal system,” Biomaterials, vol. 27, 2006, pp. 2171–2177.
[10] S. Hirayama, S. Hirayama, S. Takagi, M. Markovic, L.C. Chow, Properties of calcium phosphate cements with different tetracalcium phosphate and dicalcium phosphate anhydrous molar ratios, J. Res. Natl. Inst. Stand. Technol., vol. 113, 2008, pp. 311–320.
[11] S. Hirayama, S. Takagi, M. Markovic, L.C. Chow, “Properties of calcium phosphate cements with different tetracalcium phosphate and dicalcium phosphate anhydrous molar ratios,” J. Res. Natl. Inst. Stand. Technol., vol. 113, 2008, pp. 311–320.
[12] H. Suzuki, H. Suzuki, M. Sakurai, M. Watanabe, “The effect of stimulator on hardening of calcium phosphates,” Phos. Res. Bull., vol. 12, 2001, pp. 31–38.
[13] K. Muroyama,T. Matumoto, K. Yamashita, T. Umegaki, “Effect of addition of water-soluble polymers of hydraulically hardened calcium phosphates,” Mukimateriaru, vol. 3, 1996, pp. 380–385.
[14] M. Watanabe, M. Tanaka, M. Sukurai, M. Maeda, “Development of calcium phosphate cement,” J. Eur. Ceram. Soc., vol. 26, 2006, pp. 549– 552.
[15] S.Takagi, L.C.ChowandK.Ishikawa, “Formation of hydroxyapatite in new calcium phosphate cements,” Biomaterial, vol. 19, 1998, pp. 1593- 1599.
[16] M.P. Ginebra, C. Canal, M. Espanol, D. Pastorino, E.B. Montufar, “Calcium phosphate cements as drug delivery materials,” Adv. Drug Deliv. Rev., vol. 64, 2012, pp. 1090–1110.
[17] F. C. M. Driessens, M. G. Boltong, O. Bermudez and J. A. Planell, “Formulation and setting times of some calcium orthophosphate cements: a pilot study,” J. Mater. Sci.: Mater. Med., vol. 4, 1993, pp. 503-508.
[18] F. C. M. Driessens, J.A. Planell,M.G. Boltong, I. Khairoun and M.P. Ginebra, J. Eng. Med., “Proceedings of the Institution of Mechanical Engineers, Part H,” 1998, pp. 212-427.